Article
Dysregulated primary hemostasis in critically ill COVID-19 patients
2020-11-06
Abstract excerpt
<h4>Background: </h4> Microvascular thrombosis, as well as arterial and venous thrombotic events, have been largely described during severe Coronavirus disease 19 (COVID-19). Therapeutic anticoagulation has been proposed in critical patients, however mechanisms underlying hemostasis dysregulation remain unclear. <h4>Methods: </h4>: We explored two independent cross-sectional cohorts to identify soluble markers and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af4683cd-5b82-52b8-9e37-15790cbed274
- DOI
- 10.21203/rs.3.rs-103046/v1
